Chitosan Oligosaccharide Lactate Coated Hydroxyapatite Nanoparticles as a Vehicle for the Delivery of Steroid Drugs and the Targeting of Breast Cancer Cells.
Autor: | Ignjatović NL; Institute of Technical Sciences of the Serbian Academy of Science and Arts, Knez Mihailova 35/IV, P.O. Box 377, 11000 Belgrade, Serbia., Sakač M; University of Novi Sad, Faculty of Sciences, Department of Chemistry, Biochemistry and Environmental Protection, Trg Dositeja Obradovića 3, 21000 Novi Sad, Serbia., Kuzminac I; University of Novi Sad, Faculty of Sciences, Department of Chemistry, Biochemistry and Environmental Protection, Trg Dositeja Obradovića 3, 21000 Novi Sad, Serbia., Kojić V; Faculty of Medicine, Oncology Institute of Vojvodina, University of Novi Sad, Put Dr Goldmana 4, Sremska Kamenica 21204, Serbia., Marković S; Institute of Technical Sciences of the Serbian Academy of Science and Arts, Knez Mihailova 35/IV, P.O. Box 377, 11000 Belgrade, Serbia., Vasiljević-Radović D; University of Belgrade, Institute for Chemistry, Technology and Metallurgy, Njegoševa 12, Belgrade, Serbia., Wu VM; Advanced Materials and Nanobiotechnology Laboratory, Department of Biomedical and Pharmaceutical Sciences, Center for Targeted Drug Delivery, Chapman University, 9501 Jeronimo Road, Irvine, CA 92618, USA., Uskoković V; Advanced Materials and Nanobiotechnology Laboratory, Department of Bioengineering, University of Illinois, Chicago, IL, USA., Uskoković DP; Institute of Technical Sciences of the Serbian Academy of Science and Arts, Knez Mihailova 35/IV, P.O. Box 377, 11000 Belgrade, Serbia. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of materials chemistry. B [J Mater Chem B] 2018; Vol. 6 (43), pp. 6957-6968. Date of Electronic Publication: 2018 Oct 09. |
DOI: | 10.1039/C8TB01995A |
Abstrakt: | Low targeting efficiency and fast metabolism of antineoplastic drugs are hindrances to effective chemotherapies and there is an ongoing search for better drugs, but also better carriers. Steroid derivatives, 3β-hydroxy-16-hydroxymino-androst-5-en-17-one (A) and 3β,17β-dihydroxy-16-hydroxymino-androst-5-ene (B) as cancer growth inhibitors were chemically synthesized and captured in a carrier composed of hydroxyapatite (HAp) nanoparticles coated with chitosan oligosaccharide lactate (ChOLS). The only difference between the two derivatives is that A has a carbonyl group at the C17 position of the five-membered ring and B has a hydroxyl. This small difference in the structure resulted not only in different physicochemical properties of the A- and B-loaded HAp/ChOSL, but also in different biological activities. The morphology of drug-loaded HAp/ChOSL particles was spherical, but the size depended on the drug identity: d Competing Interests: Conflicts of interest There are no conflicts to declare. |
Databáze: | MEDLINE |
Externí odkaz: |